China Pharma Holdings, Inc. (CPHI)
| Market Cap | 25.64M |
| Revenue (ttm) | 10.11M |
| Net Income (ttm) | -3.81M |
| Shares Out | 43.58M |
| EPS (ttm) | -0.09 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 204,159 |
| Open | 0.600 |
| Previous Close | 0.614 |
| Day's Range | 0.580 - 0.610 |
| 52-Week Range | 0.350 - 1.630 |
| Beta | 0.10 |
| Analysts | n/a |
| Price Target | 3.00 (+409.9%) |
| Est. Earnings Date | n/a |
About CPHI
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of th...
Financial Performance
In 2020, CPHI's revenue was $10.87 million, a decrease of -0.53% compared to the previous year's $10.92 million. Losses were -$2.87 million, -86.15% less than in 2019.
Financial StatementsNews
China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results
HAIKOU, China, Aug. 13, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated speci...
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA A...
HAIKOU, China , Aug. 5, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its Cande...
China Pharma to Launch Highly Purified NMN+PQQ Product
HAIKOU, China, June 9, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to launch...
China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue
HAIKOU, China, May 14, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced financial resul...
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port
HAIKOU, China, April 19, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, commented on the policy state...
Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks
Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. The post Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, C...
China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results
HAIKOU CITY, China , March 26, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrate...
China Pharma Holdings: 5 Things for Potential CPHI Stock Investors to Know
Face mask play China Pharma Holdings is trending higher today, and investors are noticing. Here is what you should know about CPHI stock.
China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript
China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript
China Pharma's (CPHI) CEO Zhilin Li on Q2 2019 Results - Earnings Call Transcript
China Pharma's (CPHI) CEO Zhilin Li on Q2 2019 Results - Earnings Call Transcript
China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript
China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript
China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q4 2018 Results - Earnings Call Transcript
China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q4 2018 Results - Earnings Call Transcript